gms | German Medical Science

64. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

26. - 29. Mai 2013, Düsseldorf

Local recurrence of GBM despite complete resection: the need for function-preserving supramarginal resection

Meeting Abstract

  • Maria Angela Samis Zella - Neurochirurgische Klinik, Universitätsklinikum Düsseldorf
  • Jessica Baernreuther - Neurochirurgische Klinik, Universitätsklinikum Düsseldorf
  • Marion Rapp - Neurochirurgische Klinik, Universitätsklinikum Düsseldorf
  • Hans-Jakob Steiger - Neurochirurgische Klinik, Universitätsklinikum Düsseldorf
  • Michael Sabel - Neurochirurgische Klinik, Universitätsklinikum Düsseldorf

Deutsche Gesellschaft für Neurochirurgie. 64. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC). Düsseldorf, 26.-29.05.2013. Düsseldorf: German Medical Science GMS Publishing House; 2013. DocMI.06.07

doi: 10.3205/13dgnc328, urn:nbn:de:0183-13dgnc3286

Veröffentlicht: 21. Mai 2013

© 2013 Zella et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Objective: Due to its infiltrating growth pattern, the typical recurrence pattern of a Glioblastoma multiforme(GBM) after open resection, occurs locally. With the introduction of the fluorescence-guided resection technique, the rate of complete resections of the contrast-enhancing part of the GBM increased significantly. We were interested in finding out whether this more aggressive local surgical treatment influenced the rate of local recurrences.

Method: Inclusion criteria for this single centre, retrospective study were a complete resection of the GBM at the time of the first diagnosis. Complete resection (CR) was defined as no residual contrast enhancement (CE) in the early postoperative MRI [<72h]), followed by standard adjuvant radio-chemotherapy. All patients included in the study presented at least one recurrence. At recurrence, patients were divided into two groups according to cerebral MRI imaging (T1 sequences plus CE): patients with a local recurrence (within 2 cm from the primary tumor's margins), patients with a distant recurrence (≥2 cm from the primary tumor's margins). For the latter group, the possible mechanisms of recurrence were analyzed and found to be either by CSF dissemination, meningeal invasion, along fibre tracts or de novo. In addition, survival data were determined.

Results: We identified 46 patients, who underwent CR for a primary GBM between January 2007 and December 2011, followed by Stupp protocol. At first recurrence, among these 46 patients, 39 patients (84.7%) presented a local recurrence, 7 patients (15.3%) with a distant recurrence. Among the patients with distant recurrence, we identified 1 patient (6.6%) with CSF disseminations, 2 patients (13.3%) with de novo manifestation, 3 patients (20.0%) with recurrence along fibre tracts and 1 patient (6.6%) with meningeal localization. Median survival for patients with local recurrence (39 cases) was 22.0 months (range 3.0–83.1) versus 32.4 months (range 16.6–89.3) for the patients with distant recurrence (7 cases).

Conclusions: Despite aggressive surgical treatment with no residual CE, the vast majority of recurrences still occur locally. If functionality is not compromised, even more aggressive “supramarginal” treatment might be considered, using extensive intraoperative monitoring to avoid permanent deficits. Our data suggest that local control might be associated with superior survival, potentially supporting the concept of “function preserving supramarginal resection”.